<DOC>
	<DOCNO>NCT01477931</DOCNO>
	<brief_summary>The aim study 1 ) examine clinical utility bupropion hydrochloride extend release ( Wellbutrin XL速 ) patient Major Depressive Disorder ( MDD ) atypical feature ; 2 ) evaluate tolerability bupropion hydrochloride extend release ( Wellbutrin XL速 ) patient MDD atypical feature .</brief_summary>
	<brief_title>Interventional Study Wellbutrin XL Major Depressive Disorder With Atypical Features</brief_title>
	<detailed_description>Whether bupropion hydrochloride extend release ( Wellbutrin XL速 ) improve atypical depressive symptom investigate . The investigator assume bupropion hydrochloride extend release ( Wellbutrin XL速 ) effective tolerable treatment atypical depression MDD patient .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>Age 20 year DSMIV episode MDD nonpsychotic atypical feature characterize mood reactivity 2 symptom vegetative reversal ( include overeating , oversleep , severe fatigue leaden paralysis , history rejection sensitivity ) More 19 score 29item HAMD Ability give inform consent Bipolar depression Any Axis I psychotic disorder A history suicide attempt , selfinjurious action ( exclude action intention suicide ) overdosage ( exclude apparently accidental overdosage ) Patients 3point score suicide ( HAMD29 Item 18 ) patient whose CSSRS assessment suggest significant risk harm actually harm , , opinion investigator ( subinvestigator ) , significant risk harm self others A history substance abuse previous 12 month A history hypersensitivity bupropion component preparation use study ( Wellbutrin SR 150mg Wellbutrin XL 300 mg tablet ) Serious unstable medical disorder Starting terminate psychotherapy previous 12 week , ECT treatment previous 3 month Subject life time diagnosis anorexia nervosa bulimia within past 12 month Subject current history seizure disorder brain injury ( traumatic diseaserelated ) condition predispose seizure subject treated medication treatment regimens low seizure threshold subject undergoing abrupt discontinuation alcohol sedatives Subjects previously fail adequate course pharmacotherapy two different class antidepressant previous adequate course ( ) bupropion Pregnancy planning pregnancy patient active reproductive age , agree use relevant contraception study Patients monoamine oxidase inhibitor ( MAOIs ) Patients treated preparation contain bupropion incidence seizure dose dependent</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Bupropion hydrochloride extend release</keyword>
	<keyword>Wellbutrin XL</keyword>
	<keyword>Major Depressive Disorder Atypical Features</keyword>
</DOC>